Interestingly, such treatment effectively reduces tumor growth (Fig. 6a) and increases the percentage of CD8+ T cells among all CD45+ leukocytes recovered from the tumor mass (Fig. 6b). This evidence concerns the gene PTPRC and neoplasm.